As of 2025-07-01, the Fair Value of Vaxcyte Inc (PCVX) is -19.77 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 32.58 USD, the upside of Vaxcyte Inc is -160.67%.
With the market price of 32.58 USD and our fair value calculation, Vaxcyte Inc (PCVX) is not a good investment. Investing in PCVX stocks now will result in a potential loss of 160.67%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -89.22 | -100.08 | -223.49 | -402.00 | -464.00 | -255.76 |
| YoY growth | -77.48% | -12.17% | -123.31% | -79.87% | -15.42% | -61.65% |
| Market Cap (mil) | 4,202.82 |
| P/E | |
| Forward P/E |
| EPS | -3.95 |
| Avg earnings growth rate | -61.65% |
| TTM earnings | -510.00 |